Showing results (31-40 of 116) with videos related to
Sort By:
Pageof 12
Leukemia Research|March 12, 2021
Additional impact of mutational genotype on prognostic determination in resistant and relapsed acute myeloid leukaemiaDavid C Linch, Robert K Hills, Amanda Gilkes, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 25, 2013
Prognostic relevance of treatment response measured by flow cytometric residual disease detection in older patients with acute myeloid leukemiaSylvie D Freeman, Paul Virgo, Steve Couzens, et al.British Journal of Haematology|June 18, 2015
Guidelines for the diagnosis and management of acute myeloid leukaemia in pregnancySahra Ali, Gail L Jones, Dominic J Culligan, et al.BMC Pulmonary Medicine|January 15, 2013
The acute impact of a hematopoietic allograft on lung function and inflammation: a prospective observational studyAlexandra Enocson, Richard Hubbard, Tricia McKeever, et al.Oncotarget|April 20, 2016
Complementary dynamic BH3 profiles predict co-operativity between the multi-kinase inhibitor TG02 and the BH3 mimetic ABT-199 in acute myeloid leukaemia cellsMonica Pallis, Francis Burrows, Jeremy Ryan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 27, 2013
Curability of patients with acute myeloid leukemia who did not undergo transplantation in first remissionAlan K Burnett, Anthony Goldstone, Robert K Hills, et al.Blood|October 24, 2002
Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow TransplantationStephen P Robinson, Anthony H Goldstone, Stephen Mackinnon, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 1, 2006
The outcome of sibling and unrelated donor allogeneic stem cell transplantation in adult patients with acute myeloid leukemia in first remission who were initially refractory to first induction chemotherapyGordon Cook, Richard E Clark, Charles Crawley, et al.Stroke|November 4, 2006
Granulocyte-colony-stimulating factor mobilizes bone marrow stem cells in patients with subacute ischemic stroke: the Stem cell Trial of recovery EnhanceMent after Stroke (STEMS) pilot randomized, controlled trial (ISRCTN 16784092)Nikola Sprigg, Philip M Bath, Lian Zhao, et al.Haematologica|February 28, 2016
Defining the dose of gemtuzumab ozogamicin in combination with induction chemotherapy in acute myeloid leukemia: a comparison of 3 mg/m2 with 6 mg/m2 in the NCRI AML17 TrialAlan Burnett, Jamie Cavenagh, Nigel Russell, et al.Pageof 12